What’s Next For Guardant Health Stock After An 18% Fall In A Month?

What’s Next For Guardant Health Stock After An 18% Fall In A Month?

The stock price of Guardant Health, a healthcare company that offers non-invasive cancer diagnosis tests, has seen an 18% fall over the last twenty-one trading days. This can be attributed to its plans to acquire NeoGenomics. Both the companies offer multiple diagnostics tests for cancer patients…